Prevalence and Determinants of Hypertension Among Diabetic Patients in | DMSO – Dove Medical Press

Daba Abdissa,1 Kumsa Kene2

1Department of Biomedical Sciences Division of Clinical Anatomy, College of Medical Sciences, Institute of Health Sciences, Jimma University, Jimma, Ethiopia; 2Department of Biomedical Sciences Division of Medical Biochemistry, College of Medical Sciences, Institute of Health Sciences, Jimma University, Jimma, Ethiopia

Correspondence: Daba Abdissa Tel +251 923503701Email dhaabaa4@gmail.com

Purpose: Hypertension is a growing public health problem with a remarkable contribution to morbidity and mortality. It is a common condition which usually coexists with diabetes and aggravates its complications. The objective of this study was to assess the prevalence and determinants of hypertension among diabetic patients attending their follow-up at Jimma University Medical Center (JUMC) from June 1 to August 30, 2019.Methods: A hospital-based cross-sectional study was conducted in diabetic patients attending their follow-up at JUMC. Systematic random sampling and a pretested interviewer-administered structured questionnaire were used to collect information. Data were entered into EPI data 3.1 and exported to SPSS version 20. A variable having a p-value of < 0.25 in the bivariate model was subjected to multivariate analysis to avoid the confounding variables effect. Adjusted odds ratios were calculated at the 95% confidence interval and considered significant with a p-value of < 0.05.Results: A total of 366 diabetic patients were included in the study. Their mean age was 50.1 14.28 years, and the mean duration of diabetes was 6.8 5.3 years. The study finding showed that the prevalence of hypertension among diabetic patients was 37.4%. According to the multivariate logistic regression analysis, age of 50 years [AOR = 4.79; 95% CI: 1.4, 16.4], having body mass index (BMI) of 25 [AOR = 3.11; 95% CI: 1.58, 6.12] and khat chewing [AOR =19.34; 95% CI: 10.26, 36.44] were independent predictors of hypertension among diabetic patients.Conclusion: Our study found that there is high prevalence of hypertension among diabetic patients. Age of 50 years, having BMI of 25 kg/m2 and khat chewing were associated with hypertension among participants. Early detection and appropriate interventions should be an important action among patients with age 50 years, having BMI 25kg/m2 and khat chewers.

Keywords: prevalence, determinants, hypertension, diabetes, Southwest Ethiopia

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Go here to read the rest:
Prevalence and Determinants of Hypertension Among Diabetic Patients in | DMSO - Dove Medical Press

UHS approves proposals of reforms body – The News International

LAHORE:The 156th meeting of Advanced Studies and Research Board of the University of Health Sciences (UHS) was held here on Thursday with UHS Vice Chancellor Prof Javed Akram in the chair.

The board approved the recommendations of MD/MS/MDS Reforms Committee with regards to intermediate and final examination. It also gave a nod to the revised curricula of various specialties proposal by concerned Specialty Advisory Committees constituted by the varsity for that purpose. It was told to the members that the committee had thoroughly updated the course contents, rotational plan and table of specification for intermediate and final exams.

The curricula which have been updated include MD in dermatology, rheumatology, diagnostic radiology, and nephrology, MS in neurosurgery, general surgery, and urology; and MDS in operative dentistry, and Prosthodontics. The board considered the thesis reports of Dr Muhammad Shakil PhD (Biochemistry), Dr Munazza Saduf MPhil (Biochemistry), Dr Filza Haqiq MPhil (Community Medicine), Dr Mehvish Saleem MPhil (Science of Dental Materials), Dr Muhammad Usman Jawaid MD (Nephrology), Dr Aamir Yasin MS (General Surgery), Dr Zafar Iqbal MPhil (Anatomy), Dr. Hadia Zulfiqar M.Phil (Anatomy), Dr. Sumera Badar M.Phil (Community Medicine), Dr Mazhar Fareed MPhil (Haematology), Dr Nazia Akbar Mir MPhil (Microbiology), Dr Anum Shahid MPhil (Morbid Anatomy & Histopathology), Dr Sidra Javed MPhil (Morbid Anatomy & Histopathology), Iqra Shaukat MPhil (Medical Laboratory Sciences), Sobia Javed MPhil (Medical Laboratory Sciences), Dr Naureen Tabassum MPhil (Oral Pathology), Dr Kiran Nayyar M.Phil (Oral Pathology), Dr Sofia Yasmin Abbasi M.Phil (Pharmacology), Dr Saadia Bano Lone MPhil (Science of Dental Materials), Dr Nadia Irshad MPhil (Science of Dental Materials), Dr Noora Hassan MHPE, Dr Ambreen Fatima Khan MDS (Operative Dentistry) and Dr Muhammad Azeem MDS (Orthodontics).

The synopses of following students were also considered for registration in various postgraduate courses: Dr. Uzma Batool M.Phil (Anatomy), Dr. Hamna Umar M.Phil (Anatomy), Dr. Bushra Naheed M.Phil (Physiology), Dr. Sameen Hassan M.Phil (Haematology), Dr. Muhammad Rehan Ali M.Phil Microbiology), Dr. Nazish Kalsoom Buzdar M.Phil Microbiology), Dr. Safia Bibi M.D. (Radiology), Dr. Ali Jamal M.S. (Anaesthesia), Dr. Muhammad Irfan M.S. (Cardiac Surgery), Dr. Muhammad Muneeb M.S. (Ophthalmology) and Dr Azlan Bashir MS (Orthopaedics).

Technology graduates: Punjab Minister for Industries and Trade Mian Aslam Iqbal met with Young Engineers Technologists Association delegation headed by President Ali Hassan.

The delegation members apprised him about the problems confronting Engineering Technology Education and Technology graduates.

The delegation members informed him that the absence of National Technology Council Act bars opportunities for the technology graduates to move forward in their professional career.

They added that if such act is enforced then 3.5 lac technologists of the country will benefit. The delegation members also demanded from the minister representation of engineering technologists in NTC.

Aslam Iqbal assured the delegation that he would talk with the federal ministers concerned for activating NTC and obtaining approval of NTC Act. He added we will make every possible effort to resolve the problems of technology graduates. He remarked that the activation of NTC and enforcement of Act will enhance opportunities for the technologists.

The minister directed for formulating recommendations with regard to NTC Act and stressed that the future of Pakistan is linked with technical education. The minister underscored that the Punjab government has adopted a revolutionary strategy to promote technical education in the province. He said Tevta was playing a pivotal role in the promotion of technical education. He emphasised that the targets of progress can be speedily attained by promoting latest technology.

Read the rest here:
UHS approves proposals of reforms body - The News International

Study by U of T researchers reveals how bacterial toxins evolve to cause new illnesses – News@UofT

The coronavirus pandemic is a daily reminder of the far-reachingconsequences of apathogens successful invasion of human cells. And, as a new University of Toronto study on bacterial toxins shows, it does not take much for these encounters to turn deadly.

The research found that two almost identical bacterial toxins cause distinct illnesses diarrhea and fatal toxic shock syndrome by binding unrelated human receptors. It also highlights a mechanism by which pathogens have evolved distinct receptor preferences to infect different organs.

I always think of bacterial toxins as fascinating machines of death in how they find new ways to enter host tissue, saysMikko Taipale, an assistant professor of molecular genetics at the Donnelly Centre for Cellular and Biomolecular Research.

Taipaleco-led the study,published recently in the journalCell, withRoman MelnykandJean-Philippe Julien, both senior scientists at the Hospital for Sick Children and faculty members in U of Ts department of biochemistry.

Many are familiar withClostridium difficile, a gut-dwelling bacterium that can cause diarrhea. Lesser known is its close relative,Paeniclostridium sordellii, which also lives in the gut and in the female reproductive tract. Infections are rare but fatal and can occur when the bacterial toxin escapes into the bloodstream, during birth for example, and spreads into the lungs and other organs.

Both species are thought to be part of the microbiome, the bodys resident bacteria, but its not clear why they harm some people and not others.

The toxin released byC. difficileacts through Frizzled receptor proteins, which play a role in tissue regeneration. Yet, whileP. sordelliiproduces a similar toxin, it does not bind in the same way so the researchers set out to investigate.

They took an unbiased approach by systematically switching off every gene in human cells and exposing them to theP. sordelliitoxin. Cells that survived turned out to lack genes encoding cell surface proteins called semaphorins, and other experiments confirmed that two members of this class, Semaphorin6A and Semaphorin6B, are indeed the receptors for the toxin. Both receptors are present in the lungs, as expected, though their role there remains unclear.

Knowing the receptor opens the door to finding treatment. The researchers were able to halt infection in mice by co-injecting the toxin with purified semaphorin fragments, which bound and neutralized the toxin before it could reach the real receptors.

But the finding led to more surprises.

Like Frizzled, semaphorins play important roles in the body most notably in developing the nervous system, where they help guide projecting nerve fibers. Even more surprising was that it binds a receptor with no structural resemblance to Frizzled.

Here we have two toxins that are so similar to each other, but they use completely different receptors, says Taipale. We did not expect to find that.

The reason is a tiny differencebetween C. difficileandP. sordellii in particular, the surface though which both toxins contact their receptors, as revealed by cryo electron microscopy. Each toxin protein is composed of about 2,500 amino-acids and the researchers were able to pinpoint those that directly engage with the receptor. Swapping a mere 15 of these amino acids between the two toxins was sufficient to switch receptor preference. In other words, they created a P. sordellii toxin that targeted Frizzled and vice versa.

We were floored when we saw that the toxins shared a surface that each evolved to uniquely interact with distinct cells, says Julien.

It appears that, while the rest of the toxin is under strong evolutionary pressure to remain unchanged, the receptor-binding surface is free from such constraints. This allows toxins to evolve into variants that bind new receptors to invade other tissues and hosts.

Receptor switching is not unique to bacteria, however. SARS-CoV-2 and coronavirus strains that cause common cold use the same part of the now famous spike protein to bind to diverse receptors, which might explain differences in disease severity.

This is a nice example of how viruses and bacteria from completely different domains of life have found similar molecular tactics to change their receptor targets in human cells, says Taipale.

It also reminds us how much cool biology one can find in the microbial world.

The research was supported by the CIFAR Azrieli Global Scholar program, the Ontario Early Researcher Awards programand the Canada Research Chairs program.

Read this article:
Study by U of T researchers reveals how bacterial toxins evolve to cause new illnesses - News@UofT

O-AMINOANISOLE Market Is Set for a Rapid Growth and is Expected to Reach USD Billion by 2027: Jiaxing Zhonghua Chemical WeifangUnion Biochemistry Seya…

A new research study has been presented by Precision Market Reports (PMR) after a comprehensive analysis on O-Aminoanisole Market where user can get benefits from the complete market research report with all required useful information on market. Report discuss all major market aspects with expert opinion on current market status along with historic data as well. Detailed study Price, Share, Size & Growth, Latest News & Developments, Expansion Plan, Current Business Strategy, Top Companies, Sales, Revenue & Competitors Analysis, Production and Consumption, Demand & Supply, Industry and Business Study, Effect of Covid 19 (Buyers & Sellers) and Prediction 2020-2025.

Regions Covered in the O-Aminoanisole Market:

Covid-19 Scenario:

TOP PLAYERS:

Competitors Analysis includes market shares for all the companies listed below, Competitors Analysis revenue chart, Competitive Dashboard, and the competitors latest strategies for overcoming the Covid 19 pandemic situation.

Download Sample of This Strategic Report: https://www.precisionmarketreports.com/download-sample/292786

SEGMENTAL ANALYSIS:

Each segment is assessed on the basis of its growth rate and share. In addition, the analysts have studied potential regions that may prove rewarding to the O-Aminoanisole market in the years to come. The geographical research provides accurate value and volume forecasts, thereby helping market players gain profound insights into the O-Aminoanisole market as a whole.On the basis of product, we research the production, revenue, price, market share and growth rate, primarily split into:

Global o-Aminoanisole Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2015-2026):Purity ?99.0%Purity ?99.5%

Global o-Aminoanisole Market: Application Segment Analysis (Consumption Volume and Market Share 2015-2026; Downstream Customers and Market Analysis)Dye IntermediatePerfume IntermediatePharmaceutical Intermediate

Global o-Aminoanisole Market: Manufacturers Segment Analysis (Company and Product introduction, o-Aminoanisole Sales Volume, Revenue, Price and Gross Margin):Jiaxing Zhonghua ChemicalWeifangUnion BiochemistrySeya Industries LtdAnhui Haihua Chemical TechnoloyAnhui Zhongxin ChemicalTBI CorporationChangzhou Guanjia ChemicalAarti IndustriesChemieOrganic ChemicalsZhongdan Group

Pdf Sample Copy of this[emailprotected]: https://www.precisionmarketreports.com/download-sample/292786

What Reports Provides:

Table of Contents:1 Global Market Overview1.1 Scope of Statistics1.1.1 Scope of Products1.1.2 Scope of Manufacturers1.1.3 Scope of End-Use1.1.4 Scope of Product Type1.1.5 Scope of Regions/Countries1.2 Global Market SizeFig Global O-Aminoanisole Market Size and CAGR 2015-2019 (Million USD)Fig Global O-Aminoanisole Market Size and CAGR 2015-2019 (Volume)Fig Global O-Aminoanisole Market Forecast and CAGR 2020-2025 (Million USD)Fig Global O-Aminoanisole Market Forecast and CAGR 2020-2025 (Volume)2 Regional Market2.1 Regional SalesTab Regional Sales Revenue 2015-2019 (Million USD)Tab Regional Sales Volume 2015-2019 (Volume)2.2 Regional DemandTab Regional Demand and CAGR List 2015-2019 (Million USD)

Enquire For Customization In the Report: https://www.precisionmarketreports.com/download-sample/292786

The report offers the restraints that help to tackle the obstacles for the businesses for a tremendous growth. Through this report, consumers can easily get views on O-Aminoanisole Market based on the current scenario.

About Precision Market Reports (PMR):

Precision Market Reports provides quantified B2B research on 25,000 high-growth niche opportunities / threats that will impact 50 to 75 percent of global company revenues. Actively representing more than 5000 customers worldwide, including 50 percent of Fortune 500 global businesses as clients. Almost 25,000 top officials across eight industries worldwide approach Precision Market Reports for their pain points around revenue decisions.

Our reports provide a rare combination of concrete perspectives and qualitative research to help businesses attain sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile extensive, interspersed with relevant data, market studies.

Precision Business Reports provide objective insight and reliable data, helping companies of all sizes take timely decisions. We tailor creative solutions for our customers to help them address problems that are distinct from their business. Our aim is to empower our customers with holistic market intelligence, giving them a granular overview of the market in which they operate.

Contact:Mr.Brian SmithPrecision Market Reports169, Elisenthal,North Rhine- Westphalia,Rhehin- Sieg- Kreis,Windeck, Hohnrath,Germany, DE- 51570.Phone:+1 (845) 377-0269Website:www.precisionmarketreports.comEmail:[emailprotected]/[emailprotected]

See the original post here:
O-AMINOANISOLE Market Is Set for a Rapid Growth and is Expected to Reach USD Billion by 2027: Jiaxing Zhonghua Chemical WeifangUnion Biochemistry Seya...

Thrive on the MCAT by following this advice – American Medical Association

The Medical College Admission Test (MCAT) is one of the most factored metrics in whether a student gets into medical school though admissions offices are striving to enhance holistic admissions methods. Each year, according to the Association of American Medical Colleges (AAMC), more than 85,000 students take the exam.

The AMA has gathered expert advice to help you achieve your best MCAT score and boost your chances of medical school admission.

For students preparing for the exam in the 2020 testing cycle, the COVID-19 pandemic has thrown a curveball into their plansas it has for theentire medical school admissions process.

While administrations of the MCAT have restarted, the exam was suspended for more than a month of prime test-taking time during the height of the pandemic. Administrations of the exam will take place through late September, though there are some key differences to the exam, including length and the times at which it is offered.

Some MCAT advice is applicable in any testing cycle. In channeling expert advice for prospective test-takers, there are many keys to succeeding on the exam. Here are a few of the most important insights.

Medicine can be a career that is both challenging and highly rewarding but figuring out a medical schools prerequisites and navigating the application process can be a challenge unto itself. TheAMA premed glossary guidehas the answers to frequently asked questions about medical school, the application process, the MCAT and more.

Have peace of mind andget everything you need to start medical school off strongwith the AMA.

Read more:
Thrive on the MCAT by following this advice - American Medical Association

Global Biochemical Reagents Market 2020 | Know the Companies List Could Potentially Benefit or Loose out From the Impact of COVID-19 | Top Companies:…

A perfect mix of quantitative & qualitative Biochemical Reagentsmarket information highlighting developments, industry challenges that competitors are facing along with gaps and opportunities available and would trend in Biochemical Reagents market. The study bridges the historical data from 2014 to 2019 and estimated until 2026.

The Biochemical ReagentsMarket report also provides the market impact and new opportunities created due to the COVID19/CORONA Virus Catastrophe The total market is further divided by company, by country, and by application/types for the competitive landscape analysis. The report then estimates 2020-2026 market development trends of Biochemical ReagentsIndustry.

Download Free Sample PDF along with few company profileshttps://inforgrowth.com/sample-request/6362518/biochemical-reagents-market

The Top players are Beckton, Dickinson & Company, Merck & Co., Inc, Abbott Laboratories, Agilent Technologies, Inc, Waters Corporation., Siemens Healthineers, Thermo Fisher Scientific, Bio-Rad Laboratories, Roche Holding AG, Johnson & Johnson.

Market Segmentation:

By Product Type: Polymerase chain reaction (PCR) reagent kits, Cell and tissue culture reagents, Electrophoresis reagents, Chromatography reagents, Others

On the basis of the end users/applications, Hospitals, Diagnostic centers, Academics and Research

Downlaod Sample ToC to understand the CORONA Virus/COVID19 impact and be smart in redefining business strategies. https://inforgrowth.com/CovidImpact-Request/6362518/biochemical-reagents-market

Be the first to knock the door showing the potential that Biochemical Reagentsmarket is holding in it. Uncover the Gaps and Opportunities to derive the most relevant insights from our research document to gain market size.

A major chunk of this Global Biochemical ReagentsMarket research report is talking about some significant approaches for enhancing the performance of the companies. Marketing strategies and different channels have been listed here. Collectively, it gives more focus on changing rules, regulations, and policies of governments. It will help to both established and new startups of the market.

The study objectives of this report are:To analyze global Biochemical Reagentsstatus, future forecast, growth opportunity, key market, and key players.To present the Biochemical Reagentsdevelopment in the United States, Europe, and China.To strategically profile the key players and comprehensively analyze their development plan and strategies.To define, describe and forecast the market by product type, market, and key regions.

Get Special Discount Up To 50%, https://inforgrowth.com/discount/6362518/biochemical-reagents-market

Major Points from Table of Contents

1 Biochemical Reagents Biochemical Reagents Market Overview2 Biochemical Reagents Market Competition by Manufacturers3 Production Capacity by Region4 Global Biochemical Reagents Market by Regions5 Production, Revenue, Price Trend by Type6 Global Biochemical Reagents Market Analysis by Application7 Company Profiles and Key Figures in Biochemical Reagents Business8 Biochemical Reagents Manufacturing Cost Analysis9 Marketing Channel, Distributors and Customers10 Market Dynamics11 Production and Supply Forecast12 Consumption and Demand Forecast13 Forecast by Type and by Application (2021-2026)14 Research Finding and Conclusion15 Methodology and Data Source.

ENQUIRE MORE ABOUT THIS REPORT AT https://inforgrowth.com/enquiry/6362518/biochemical-reagents-market

FOR ALL YOUR RESEARCH NEEDS, REACH OUT TO US AT:Address: 6400 Village Pkwy suite # 104, Dublin, CA 94568, USAContact Name: Rohan S.Email:[emailprotected]Phone: +1-909-329-2808UK: +44 (203) 743 1898Website: http://www.inforgrowth.com

Read the rest here:
Global Biochemical Reagents Market 2020 | Know the Companies List Could Potentially Benefit or Loose out From the Impact of COVID-19 | Top Companies:...

Century Therapeutics Announces Acquisition of Empirica Therapeutics – Business Wire

PHILADELPHIA--(BUSINESS WIRE)--Century Therapeutics today announced its acquisition of Empirica Therapeutics to leverage its iPSC-derived allogeneic cell therapies against glioblastoma (GBM).

We are pleased to welcome the Empirica team to the Century family. Their deep expertise and unique capabilities will allow us to accelerate efforts to develop iPSC derived immune effector cell products designed to treat and potentially cure brain cancer, said Lalo Flores, PhD, Chief Executive Officer of Century Therapeutics. GBM is a particularly aggressive, often treatment-resistant form of adult brain cancer with an average survival time of under two years. Together, we are in a stronger position to develop potentially curative cell therapies for this devastating disease.

Empirica Therapeutics was founded by Dr. Sheila Singh, MD, PhD, Professor of Surgery and Biochemistry and chief pediatric neurosurgeon at McMaster Childrens Hospital, and Dr. Jason Moffat, PhD, Professor of Molecular Genetics at the University of Toronto and an expert in functional genomics and gene-editing platforms. The companys science is based on a powerful integrative multi-omics platform, combined with its unique patient-derived, therapy-adapted models of recurrent GBM, that has led to the discovery and validation of novel brain tumor targets. Empiricas cutting edge preclinical models of recurrent GBM, have demonstrated the potential of CAR-T cell therapy in GBM, as published in a May 2020 Cell Stem Cell paper.

Our team is excited to become part of Century Therapeutics, whose iPSC-derived allogeneic cell therapies show immense potential for treating solid as well as hematologic malignancies, said Dr. Singh. Dr. Singh served as Empiricas CEO after co-founding the company with Chief Scientific Officer Dr. Moffat. We look forward to combining our unique patient-based cancer models with Centurys platform to create promising treatments for the patients who need them most, Singh said.

Janelle Anderson, PhD, Chief Strategy Officer at Century Therapeutics, shepherded the deal forming the subsidiary, which will be known as Century Therapeutics Canada and based in Hamilton, Ontario. Financial terms of the deal have not been disclosed.

About Century Therapeutics

Century Therapeutics is harnessing the power of stem cells to develop curative cell therapy products for cancer that overcome the limitations of first-generation cell therapies. Our genetically engineered, universal iPSC-derived immune effector cell products (iNK, iT) are designed to specifically target hematologic and solid tumor cancers. Our commitment to developing off-the-shelf cell therapies will expand patient access and provides an unparalleled opportunity to advance the course of cancer care. Century was launched in 2019 by founding investor Versant Ventures in partnership with Fujifilm and Leaps by Bayer. For more information, please visit http://www.centurytx.com.

About Glioblastoma (GBM)

Glioblastoma (GBM) is one of the most common types of primary brain tumor in adults and is almost uniformly lethal, with less than 5% of patients living beyond five years. GBM has an incidence rate of 3 per 100,000 people annually in the United States of America. The standard of care for GBM consists of tumor resection following by chemotherapy and radiation. Despite aggressive multimodal treatment, almost all patients experience relapse 7-9 months post-diagnosis and median survival has not extended beyond 16-20 months over the past decade. Recent studies suggest that the primary GBM tumor evolves significantly during the course of therapy and presents itself as a much more aggressive tumor at the time of recurrence. The treatment-resistant nature of GBM to standard therapies provides compelling motivation for developing novel treatment approaches.

Read more:
Century Therapeutics Announces Acquisition of Empirica Therapeutics - Business Wire

Infectious diseases block inaugurated at Srinagars SKIMS – Hindustan Times

Sher-i-Kashmir Institute of Medical Sciences (SKIMS) Soura on Monday further strengthened advanced patient care services with the inauguration of Infectious diseases block (IDB).

The inauguration was done by advisor to L-G of Jammu & Kashmir, Baseer Ahmad Khan.

It is the first centre of its kind in north India which is equipped with superlative quality facilities. The services that will be provided include 40-bed isolation ward, l5-bed high dependency isolation ward and intensive care unit (ICU).

The centre will also have four-bedded RO and dialysis unit, independent portable x-ray, USG machine and ECG, lab facilities for haemogram coagulation studies arterial blood gas and electrolyte analysis, biochemistry etc.

SKlMS director Dr AG Ahangar dedicated the IDB to the patient care, especially the engineering department, and other supportive management services for making this possible in short span of time against all odds.

Ahangar expressed satisfaction about the safety measures taken at all levels to ensure protection of frontline health workers.

Go here to see the original:
Infectious diseases block inaugurated at Srinagars SKIMS - Hindustan Times

Efficacy of maternal B12 supplementation in vegetarian women for improving infant neurodevelopment: protocol for the MATCOBIND multicentre,…

This article was originally published here

Efficacy of maternal B12 supplementation in vegetarian women for improving infant neurodevelopment: protocol for the MATCOBIND multicentre, double-blind, randomised controlled trial.

BMJ Open. 2020 May 25;10(5):e034987

Authors: Nagpal J, Mathur MR, Rawat S, Nagrath D, Lee C, Singhal A, Heys M, Cortina Borja M, Augustin K, Gautam J, Pant R, Swabey L, Lakhanpaul M

AbstractINTRODUCTION: Vitamin B12 deficiency is widely prevalent across many low- and middle-income countries, especially where the diet is low in animal sources. While many observational studies show associations between B12 deficiency in pregnancy and infant cognitive function (including memory, language and motor skills), evidence from clinical trials is sparse and inconclusive.METHODS AND ANALYSIS: This double-blind, multicentre, randomised controlled trial will enrol 720 vegetarian pregnant women in their first trimester from antenatal clinics at two hospitals (one in India and one in Nepal). Eligible mothers who give written consent will be randomised to receive either 250 mcg methylcobalamin or 50 mcg (quasi control), from enrolment to 6 months post-partum, given as an oral daily capsule. All mothers and their infants will continue to receive standard clinical care. The primary trial outcome is the offsprings neurodevelopment status at 9 months of age, assessed using the Development Assessment Scale of Indian Infants. Secondary outcomes include the infants biochemical B12 status at age 9 months and maternal biochemical B12 status in the first and third trimesters. Maternal biochemical B12 status will also be assessed in the first trimester. Modification of association by a priori identified factors will also be explored.ETHICAL CONSIDERATIONS AND DISSEMINATION: The study protocol has been approved by ethical committees at each study site (India and Nepal) and at University College London, UK. The study results will be disseminated to healthcare professionals and academics globally via conferences, presentations and publications. Researchers at each study site will share results with participants during their follow-up visits.Trial registration numberCTRI/2018/07/015048 (Clinical Trial Registry of India); NCT04083560 (ClinicalTrials.gov).

PMID: 32457078 [PubMed in process]

Read more:
Efficacy of maternal B12 supplementation in vegetarian women for improving infant neurodevelopment: protocol for the MATCOBIND multicentre,...

COVID-19 Update: Global Laboratory Biochemical Reagent Market is Expected to Grow at a Healthy CAGR with Top players: Beckton, Dickinson &…

A perfect mix of quantitative & qualitative Laboratory Biochemical Reagentmarket information highlighting developments, industry challenges that competitors are facing along with gaps and opportunities available and would trend in Laboratory Biochemical Reagent market. The study bridges the historical data from 2014 to 2019 and estimated until 2026.

The Laboratory Biochemical ReagentMarket report also provides the market impact and new opportunities created due to the COVID19/CORONA Virus Catastrophe The total market is further divided by company, by country, and by application/types for the competitive landscape analysis. The report then estimates 2020-2026 market development trends of Laboratory Biochemical ReagentIndustry.

Download Free Sample PDF along with few company profileshttps://inforgrowth.com/sample-request/6362482/laboratory-biochemical-reagent-market

The Top players are Beckton, Dickinson & Company, Merck & Co. Inc., Abbott Laboratories, Agilent Technologies, Inc., Waters Corporation, Siemens Healthineers, Thermo Fisher Scientific Inc, Bio-Rad Laboratories, Roche Holding AG, Johnson & Johnson.

Market Segmentation:

By Product Type: PCR Reagent Kits, Cell and Tissue Culture Reagents, Electrophoresis Reagents, Chromatography Reagents, Others

On the basis of the end users/applications, Hospitals, Diagnostic Centers, Academics and Research, Pharma and Biotech Companies, CROs

Downlaod Sample ToC to understand the CORONA Virus/COVID19 impact and be smart in redefining business strategies. https://inforgrowth.com/CovidImpact-Request/6362482/laboratory-biochemical-reagent-market

Be the first to knock the door showing the potential that Laboratory Biochemical Reagentmarket is holding in it. Uncover the Gaps and Opportunities to derive the most relevant insights from our research document to gain market size.

A major chunk of this Global Laboratory Biochemical ReagentMarket research report is talking about some significant approaches for enhancing the performance of the companies. Marketing strategies and different channels have been listed here. Collectively, it gives more focus on changing rules, regulations, and policies of governments. It will help to both established and new startups of the market.

The study objectives of this report are:To analyze global Laboratory Biochemical Reagentstatus, future forecast, growth opportunity, key market, and key players.To present the Laboratory Biochemical Reagentdevelopment in the United States, Europe, and China.To strategically profile the key players and comprehensively analyze their development plan and strategies.To define, describe and forecast the market by product type, market, and key regions.

Get Special Discount Up To 50%, https://inforgrowth.com/discount/6362482/laboratory-biochemical-reagent-market

Major Points from Table of Contents

1 Laboratory Biochemical Reagent Laboratory Biochemical Reagent Market Overview2 Laboratory Biochemical Reagent Market Competition by Manufacturers3 Production Capacity by Region4 Global Laboratory Biochemical Reagent Market by Regions5 Production, Revenue, Price Trend by Type6 Global Laboratory Biochemical Reagent Market Analysis by Application7 Company Profiles and Key Figures in Laboratory Biochemical Reagent Business8 Laboratory Biochemical Reagent Manufacturing Cost Analysis9 Marketing Channel, Distributors and Customers10 Market Dynamics11 Production and Supply Forecast12 Consumption and Demand Forecast13 Forecast by Type and by Application (2021-2026)14 Research Finding and Conclusion15 Methodology and Data Source.

ENQUIRE MORE ABOUT THIS REPORT AT https://inforgrowth.com/enquiry/6362482/laboratory-biochemical-reagent-market

FOR ALL YOUR RESEARCH NEEDS, REACH OUT TO US AT:Address: 6400 Village Pkwy suite # 104, Dublin, CA 94568, USAContact Name: Rohan S.Email:[emailprotected]Phone: +1-909-329-2808UK: +44 (203) 743 1898Website: http://www.inforgrowth.com

Read more from the original source:
COVID-19 Update: Global Laboratory Biochemical Reagent Market is Expected to Grow at a Healthy CAGR with Top players: Beckton, Dickinson &...

Floor-Standing Automatic Biochemical Analyzer Market Growth by Top Companies, Trends by Types and Application, Forecast to 2026 – Cole of Duty

Urit

Moreover, the Floor-Standing Automatic Biochemical Analyzer report offers a detailed analysis of the competitive landscape in terms of regions and the major service providers are also highlighted along with attributes of the market overview, business strategies, financials, developments pertaining as well as the product portfolio of the Floor-Standing Automatic Biochemical Analyzer market. Likewise, this report comprises significant data about market segmentation on the basis of type, application, and regional landscape. The Floor-Standing Automatic Biochemical Analyzer market report also provides a brief analysis of the market opportunities and challenges faced by the leading service provides. This report is specially designed to know accurate market insights and market status.

By Regions:

* North America (The US, Canada, and Mexico)

* Europe (Germany, France, the UK, and Rest of the World)

* Asia Pacific (China, Japan, India, and Rest of Asia Pacific)

* Latin America (Brazil and Rest of Latin America.)

* Middle East & Africa (Saudi Arabia, the UAE, , South Africa, and Rest of Middle East & Africa)

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketresearchintellect.com/ask-for-discount/?rid=247369&utm_source=NYH&utm_medium=888

Table of Content

1 Introduction of Floor-Standing Automatic Biochemical Analyzer Market

1.1 Overview of the Market1.2 Scope of Report1.3 Assumptions

2 Executive Summary

3 Research Methodology

3.1 Data Mining3.2 Validation3.3 Primary Interviews3.4 List of Data Sources

4 Floor-Standing Automatic Biochemical Analyzer Market Outlook

4.1 Overview4.2 Market Dynamics4.2.1 Drivers4.2.2 Restraints4.2.3 Opportunities4.3 Porters Five Force Model4.4 Value Chain Analysis

5 Floor-Standing Automatic Biochemical Analyzer Market, By Deployment Model

5.1 Overview

6 Floor-Standing Automatic Biochemical Analyzer Market, By Solution

6.1 Overview

7 Floor-Standing Automatic Biochemical Analyzer Market, By Vertical

7.1 Overview

8 Floor-Standing Automatic Biochemical Analyzer Market, By Geography

8.1 Overview8.2 North America8.2.1 U.S.8.2.2 Canada8.2.3 Mexico8.3 Europe8.3.1 Germany8.3.2 U.K.8.3.3 France8.3.4 Rest of Europe8.4 Asia Pacific8.4.1 China8.4.2 Japan8.4.3 India8.4.4 Rest of Asia Pacific8.5 Rest of the World8.5.1 Latin America8.5.2 Middle East

9 Floor-Standing Automatic Biochemical Analyzer Market Competitive Landscape

9.1 Overview9.2 Company Market Ranking9.3 Key Development Strategies

10 Company Profiles

10.1.1 Overview10.1.2 Financial Performance10.1.3 Product Outlook10.1.4 Key Developments

11 Appendix

11.1 Related Research

Get Complete Report

@ https://www.marketresearchintellect.com/need-customization/?rid=247369&utm_source=NYH&utm_medium=888

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage and more. These reports deliver an in-depth study of the market with industry analysis, market value for regions and countries and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Tags: Floor-Standing Automatic Biochemical Analyzer Market Size, Floor-Standing Automatic Biochemical Analyzer Market Trends, Floor-Standing Automatic Biochemical Analyzer Market Growth, Floor-Standing Automatic Biochemical Analyzer Market Forecast, Floor-Standing Automatic Biochemical Analyzer Market Analysis Sarkari result, Government Jobs, Sarkari naukri, NMK, Majhi Naukri,

Our Trending Reports

Pharmaceutical Logistics Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Transformer Oil Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

See the original post:
Floor-Standing Automatic Biochemical Analyzer Market Growth by Top Companies, Trends by Types and Application, Forecast to 2026 - Cole of Duty

COVID19 Impact: Global Veterinary biochemistry analyzers Market Trend, Strengths, Threats, Research Report and Forecast (2020 To 2027) – Azizsalon…

The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes in market conditions. The rapidly changing market scenario and initial and future assessment of the impact is covered in the report.

A new informative research report on the global Veterinary biochemistry analyzers market has been recently added by Million Dollar Research to its database. It covers different business parameters such as global market trends, market shares, market size, drivers, restraints and various geographies across the world. The primary and secondary research methodologies have been used to analyze the global market research terminologies.

Get Sample Copy of this Report: http://www.milliondollarresearch.com/global-veterinary-biochemistry-analyzers-market/8736/#RequestSample

The Top Key Players include: Abaxis Europe, AMS Alliance, Biochemical Systems International, BPC BioSed, Carolina Liquid Chemistries, Crony Instruments, DiaSys Diagnostic Systems, Eurolyser Diagnostica, Gesan Production, Heska, I.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on key countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia and South Africa. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub-segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures. The report provides data tables, includes charts and graphs for visual analysis.

The study assesses factors such as segmentation, description, and applications of Veterinary biochemistry analyzers industries. It derives accurate insights to give a holistic view of the dynamic features of the business, including shares, profit generation, thereby directing focus on the critical aspects of the business. Moreover, it explains the most important aspects of the businesses which help to drive the business flow successfully. An exploration of drivers helps out to clarify the businesss growing factor over the forecast period.

Global Veterinary biochemistry analyzers Market Key Segments:

For product type segment, this report listed main product type of Veterinary Biochemistry Analyzers market in global. Automatic Semi-automatic

For end use/application segment, this report focuses on the status and outlook for key applications. End users are also listed. Pet Hospital Veterinary Station Other

Get Special Pricing: http://www.milliondollarresearch.com/global-veterinary-biochemistry-analyzers-market/8736/#AskForDiscount

This industry report analyses the market estimates and forecasts of all the given segments on a global as well as regional levels. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 to 2027. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

Following questions are addressed through this global research report:

Table of Content (TOC)

Global Veterinary biochemistry analyzers Market Research Report

Chapter 1 Global Veterinary biochemistry analyzers Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export

Chapter 6 Production, Revenue (Value), Price Trend by Type

Chapter 7 Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Market Forecast

For More Information: http://www.milliondollarresearch.com/global-veterinary-biochemistry-analyzers-market/8736/

Any special requirements about this report, please let us know and we can provide custom report.

More:
COVID19 Impact: Global Veterinary biochemistry analyzers Market Trend, Strengths, Threats, Research Report and Forecast (2020 To 2027) - Azizsalon...

Global Automated Biochemical Analyzers Market Report 2019 Significant Trends and Factors Driving the Market Development Forecast to 2025 – The Think…

UpMarketResearch, the fastest growing market research company, has published a report on the Automated Biochemical Analyzers market. This market report provides a holistic scope of the market which includes future supply and demand scenarios, changing market trends, high growth opportunities, and in-depth analysis of the future market prospects. The report covers the competitive data analysis of the emerging and prominent players of the market. Along with this, it provides comprehensive data analysis on the risk factors, challenges, and possible new market avenues.

The report has been prepared with the help of a robust research methodology to cover the market in a detailed manner. To publish a top-notch Global Automated Biochemical Analyzers Market report, the market report has undergone extensive primary and secondary research. The dedicated research team conducted interviews with the delegated industry experts to lay out a complete overview of the market. This market research report covers the product pricing factors, revenue drivers, and growth. Furthermore, it can possibly assist the new entrants and even the existing industry players to tailor a strategic business strategy for their products.

You can buy the sample report @ https://www.upmarketresearch.com/home/requested_sample/53939

Impact of COVID-19 to the Automated Biochemical Analyzers Report

This coronavirus outbreak has led various industry players to change business strategies and innovate their products. Moreover, it has created lucrative opportunities and few fallbacks that has revamped the overall industry. This report has integrated the data influenced by the COVID-19 effect and provided granular analysis on what market segments would play a crucial role in the growth of the Automated Biochemical Analyzers market. It also includes insights into the successful strategies implemented by the leading players to stay ahead in the competition.

The market research team has been closely monitoring the market since 2015 and has covered the wide spectrum of the market to provide insightful data for the forecast period 2020-2027. UpMarketResearch has provided crucial data in a graphical representation with the help of tables, bar graphs, pie charts, histograms, and infographics. To give a detailed analysis of the market, the market segments have been fragmented into sub-segments. The segments drivers, challenges, and restraints are also considered which is vital for the market growth. Besides this, it also covers the impacts of government regulation policies and regulations on the market.

You can buy the complete report @ https://www.upmarketresearch.com/buy/automated-biochemical-analyzers-market-research-2019

5 Reasons to Choose UpMarketResearch to Buy This Market Report

Market Segmentation Covered in the Report

By Product Type

Floor-standingBench-top

By Applications

Primary HospitalPrefectural HospitalProvincial Hospital

By Regional Analysis

Asia Pacific: China, Japan, India, and Rest of Asia PacificEurope: Germany, the UK, France, and Rest of EuropeNorth America: The US, Mexico, and CanadaLatin America: Brazil and Rest of Latin AmericaMiddle East & Africa: GCC Countries and Rest of Middle East & Africa

Competitive Landscape

The major players of the Automated Biochemical Analyzers market are:

Beckman CoulterHitachiRocheKHBThermo ScientificDiruiToshibaGaomi CaihongSunostikUritMindray MedicalAbbottSenloTecom ScienceSiemens HealthcareRayto

*Note: Additional companies detailed analysis can be added in the report.

If you have any questions on this report, please reach out to us @ https://www.upmarketresearch.com/home/enquiry_before_buying/53939

Table of Content of the Report

Executive Summary

Assumptions and Acronyms Used

Research Methodology

Automated Biochemical Analyzers Market Overview

Global Automated Biochemical Analyzers Market Analysis and Forecast by Type

Global Automated Biochemical Analyzers Market Analysis and Forecast by Application

Global Automated Biochemical Analyzers Market Analysis and Forecast by Sales Channel

Global Automated Biochemical Analyzers Market Analysis and Forecast by Region

North America Automated Biochemical Analyzers Market Analysis and Forecast

Latin America Automated Biochemical Analyzers Market Analysis and Forecast

Europe Automated Biochemical Analyzers Market Analysis and Forecast

Asia Pacific Automated Biochemical Analyzers Market Analysis and Forecast

Asia Pacific Automated Biochemical Analyzers Market Size and Volume Forecast by Application

Middle East & Africa Automated Biochemical Analyzers Market Analysis and Forecast

Competition Landscape

About the company

UpMarketResearch is the largest aggregator of the market research report in the industry with more than 800 global clients. The company has extensively invested in the research analysts training and programs to keep the analyst tapped with the best industry standards and provide the clients with the utmost experience. Our dedicated team has been collaborating with industry experts to give out the precise data and figures related to the industry. It conducts primary research, secondary research, and consumer surveys to provide an in-depth analysis of the market. The market research firm has worked in several business verticals and has been successful to earn high credentials over time.

Contact Info UpMarketResearchName Alex MathewsEmail [emailprotected]Website https://www.upmarketresearch.comAddress 500 East E Street, Ontario, CA 91764, United States.

See the rest here:
Global Automated Biochemical Analyzers Market Report 2019 Significant Trends and Factors Driving the Market Development Forecast to 2025 - The Think...

New COVID-19 test kit being rapidly developed using algae – CTV News London

LONDON, ONT. -- The number of COVID-19 cases across the country could be higher than we know, according to a group of scientists at Western University.

"We are underestimating the number of people in the population who have been exposed to the virus," says Dr. Dave Edgell in the Department of Biochemistry at Western's Schulich School of Medicine and Dentistry.

"There are some estimates that there may be 10 to 20 times more people infected that are actually being reported as confirmed cases of COVID."

Edgell says thats why his team, in collaboration with Suncor, are working at rapidly developing COVID-19 test kits that would determine if someone has been previously infected and has antibodies for the virus.

"The test will tell you if you have antibodies that your immune system has created to combat the virus."

Dr. Greg Gloor, also from Schulich's Department of Biochemistry says these kits could help researchers investigate herd immunity.

"In order to contain this outbreak we need to know who is currently infected and who has been infected. People who have been infected and have developed a high enough immunity probably have less to fear than people who have not been infected."

The research team is developing these kits by using algae. A new concept that they say would allow tests to be made more cost-effective with the goals of it reaching more people.

"This is where algae comes in, because it can be grown in sea water and sunlight and it doesnt cost anything really compared to the way people make the viral antigens now," says Edgell.

The hopes are to roll out these tests kits by late fall, once production and testing of efficacy is complete.

Visit link:
New COVID-19 test kit being rapidly developed using algae - CTV News London

Getting out of lockdown: Leaders from different sections of Cork society have their say – Echo Live

Taoiseach Leo Varadkar is due to announce a roadmap for the country to exit lockdown, but has said the easing of restrictions will be slow and gradual.

He said changes will be made every two to four weeks.

Unfortunately for those who would like an immediate return to a pre-Covid world, the easement of the current restrictions will be slow and gradual, said Mr Varadkar.

Today, The Echo hears from different sections of Cork society the elderly, a bar owner, construction leader, hotelier, and health expert who outline their hopes, fears and frustrations as a new normal beckons.

Pubs need to be on the same reopening timeline as restaurants and cafes, Cork City chairperson of Vintners Federation of Ireland Michael ODonovan has said.

Mr ODonovan said hospitality establishments share customers and it would be an unfair advantage to have certain sectors of the industry opening over others.

We are hoping all hospitality outlets will be on an equal footing, Mr ODonovan said.

If people have choice, it is good for the consumer. All we are asking for is a level playing field.

Mr ODonovan said many of the pubs that offer food service are possibly better able to provide enough space to socially distance.

There are a lot of pubs doing food that are bigger than restaurants and better able to physically distance.

He said any issues in relation to a lapse of social distancing was something that would be experienced across the sector regardless of the outlet. Most restaurants serve wine, spirits and craft beers, they are in direct competition with food bars, the same issues apply.

Mr ODonovan said the most important thing they would like to see come out of todays announcement is clear guidelines on what they need to do in order to reopen.

The Vintners yesterday revealed that 60% of Dublin pub owners say they will go out of business if they have to stay closed until next year.

The cocooning elderly are crumbling under the pressure of confinement and loneliness due to the current restrictions, according to older persons advocate Paddy OBrien.

Mr OBrien said he would like to see some concessions given to the elderly going forward, such as allowing them to go for a spin in their cars and walk within an extended radius of 5km or 6km.

He is very concerned about the elderly getting depressed.

People are collapsing under the pressure, it is becoming too much for them.

The loneliness is becoming depression.

It is very serious, a lot of sad, depressed people are definitely affected by this. I am concerned about people living with no contact.

Contact is vital and I am very concerned about the effect it is having on people.

They are confined and must adhere to the guidelines, as we all have a role to play, but if there were some changes made it might be easier to manage.

Mr OBrien said a month ago, people were saying it would be grand, now the gardening is done, the house is cleaned, the presses are organised, there is nothing left to do. People know they are negative, they have no zest, their heart is gone out of them.

A large number of people over 70 are driving and they are telling me they would give anything to be able to go for a spin.

Ireland must double its Covid-19 testing capacity and ensure reliable results are available within 24 hours to safely reopen society, an expert in biochemistry at University College Cork (UCC) has said.

Tom Cotter has been professor of biochemistry at UCC since 1995.

He says for society to safely reopen, there must be a dramatic increase in testing capacity for Covid-19 and an effective antibody test to determine whether people had the virus and have now recovered.

When society is opened up once again, we have to be able to test people very, very quickly, he said.

There are two things the Government needs to do before they start opening up everything again theyll need a very good antibody test and theyll need a PCR [polymerise chain reaction] test for the virus, and they will need to be available within a 24 hour period.

When lockdown is released and people are out and about, if anyone gets sick they need to be tested along with everybody theyve come into contact with, within 24 hours, he added.

PCR testing and antibody testing are the main methods of testing being used across the globe in the fight against Covid-19.

The antibody test will tell you whether youve had the coronavirus before or not, and are therefore probably immune or not, said Prof Cotter.

The PCR test will tell you if you have the virus and are infected. These two tests need to be streamlined with a turnaround time of 24 hours so that if there is another outbreak of the virus, we can catch it straight away, he added.

Some of the antibody tests that are available now are good while others are bad we need to make sure we have a really good one to tell if people have been infected and have recovered.

This test tells you if you have antibodies from the virus which means you had it and are now OK.

Then youre immune to it but for how long, we actually dont know at the moment.

Prof Cotter said that the Government is likely to release some parts of industry in Ireland on a step-by-step basis.

Theyll loosen low-risk areas like construction and hardware stores, and then theyll watch to see what happens, he said.

If the infection rates dont go up, theyll release another sector or group of jobs, and theyll watch again then theyll keep going like that.

Its a watching and waiting game because we cant afford to have another outbreak of this, he added.

CLARITY and financial support are what the hotels of Cork want to hear from Taoiseach Leo Varadkar today as the roadmap to a new normal is announced.

Chairperson of the Cork branch of the Irish Hotels Federation, Fergal Harte, said for the duration of the pandemic, the landscape of the hospitality sector will be significantly altered.

Social and physical distancing in its current guise is extremely difficult, there is no question about it.

All of the things that we want to promote in our hotels, in terms of a nice atmosphere, enjoyable ambience, and a social element are all becoming difficult to create if people are confined and cant mix, and even from the perspective of a restaurant or a bar, you have to restrict the numbers and space people out.

All the things we associate with hotels will be changed for this period anyway.

Mr Harte said there were a number of challenges to face, but that the Irish Hotels Federation was looking at it with an open mind.

We are making plans and looking to the future, hotels are anxious to reopen, but we need clarity and support, financial supports to make the industry viable.

In terms of financial assistance, the Mr Harte said the organisation was calling on the Government to waive local authority rates and water charges for 12 months as well as a reduced Vat rate of 0% for 12 months, business interruption grants, and work to provide support from the banks.

The managing director of Blackwater Motors, Denis Murphy, says he is frustrated and angry by the ongoing lockdown.

Mr Murphy said he did not understand why they could not go back to work next Tuesday, May 5.

As it goes on, it is becoming more difficult, people are becoming more and more disillusioned, they are not afraid of the virus anymore, they are afraid for their livelihoods, said Mr Murphy.

He said his staff are worried about what is going to happen in the industry if they do not get up and running soon.

Eighty-five per cent of businesses are closed or substantially reduced. That is colossal, he said.

The guys making the decisions dont own businesses, they are still getting paid, they still have their pensions.

Mr Murphy said he would like to see more transparency in the decision-making process.

He said that the reason for the lockdown was to prevent a surge and if hospitals are managing at the moment, surely then businesses should be allowed to recommence in line with strict social distancing and other guidelines.

I cant see why we are not opening next Tuesday, he said. They must think we are totally irresponsible and unable to follow these social distancing guidelines.

CORK developer Michael OFlynn believes now is the right time for construction work across the country to restart.

He said that if social housing has been deemed safe to be built, private housing can be dealt with similarly.

His company was in the process of delivering around 200 houses in Cork and Dublin at the time construction was deemed non-essential, and he had to lay off around 500 people who were either directly employed or subcontracting at a number of sites around the country.

However, with an updated announcement expected today on restrictions, Mr OFlynn said he sees no reason why construction couldnt restart with adequate procedures in place.

We have all embraced the restrictions for five weeks now. I absolutely understand that the health issue has to come first, but I think part of our industry can restart in a safe way, he said.

Mr OFlynn outlined a number of steps the industry has taken, including the development of new operating procedures and manuals being circulated, in preparation for a safe return to work.

Im very hopeful, especially given that social housing sites have been back for the last week now.

Private housing is the same method of construction as social housing, so if someone could form a conclusion that social housing is safe, then private housing must be safe, but only on the basis that theres total adherence to the HSE guidelines, Mr OFlynn told.

I think housing is a special case. In a lot of countries housing never closed. I appreciate the decision here was to do that, and for all the right reasons, he said.

Having said that, everything has to be considered, and I think now is the time to consider easing back, but only if it can be done safely.

Link:
Getting out of lockdown: Leaders from different sections of Cork society have their say - Echo Live

‘I’m definitely disappointed:’ incoming freshmen face new set of challenges for the fall | The Retriever – The Retriever

Francesca Burton is doing an individualized study in neuroscience and picking up a second major in biochemistry. Photo courtesy of Francesca Burton.

The freshman experience at the University of Maryland, Baltimore County usually includes the bonfire, Involvement Fest, kickbacks in dorms and D-Hall trips. But for this years class of incoming freshmen, many of whom lost part of high school, everything is different now socially-distanced, hybrid or online.

Roshnee Roberts, a biological sciences major and psychology minor, knew March 13 was going to be her last day of high school. Her track season cut short, her plans to speak at graduation cancelled, senior activities and hanging out with friends suddenly not allowed, and her life radically altered.

This fall, shell be attending UMBC from her home, opting not to live on campus. Unfortunately, I was really hoping [that I would be living] on campus. But you know, the way money is set up [its] not happening, which is totally fine, she said.

She was excited to get a placement in a lab, but shes still not sure if shell be able to even go on campus, Roberts said. Everyone else gets to experience all the fun senior activities and I didnt. Now, Im also missing out on freshman year, which is probably the best year, because youre meeting everyone [for the first time], she said.

It leaves her wondering what the future will look like when shes finally able to be on campus under more typical circumstances. Am I going to feel like a freshman? Because everyone else is going to know the [campus], said Roberts.

Luckily, Roberts was able to earn a full scholarship through the Dawg Days: Jumpstart Scholarship to take online classes this summer. Im taking a summer class right now, completely free of cost, which is very exciting, she said. Im taking Math 105, just to get my math credit out of the way.

Computer engineering major Kwadwo Ansah Baah, who lives in Baltimore, is also taking a math credit to get ahead with the help of the Jumpstart Scholarship, and while its not exactly what he had envisioned for his summer, he really likes his professor and class. We all crack jokes to lighten the mood. Im getting to know other people. The Jumpstart Scholarship community is great. We have game nights and everything too, he said.

His outlook is mostly positive, even faced with the adversity of missing out on some activities, hes choosing to look at the situation realistically. I was looking forward [to campus life], but [its] all right. I really understand the way the world is at this moment, he said.

While taking classes from home, his parents have been supportive throughout, giving him the space he needs to complete his schoolwork uninterrupted. My mom and dad understand that this is very important for me. When Im having classes, theyll text me rather than barge into my room, Ansah Baah said, laughing.

His sense of humor hasnt been diminished by the situation at hand, either. He doesnt plan to let the virtual classes stop him from meeting other people or from making others laugh. I believe I can still have the UMBC experience. I still crack jokes [in Zoom or Google Meet] as if you were in an in-person class. I know this pandemic is not going to go on forever, he said.

For others, the pandemic has made them reevaluate what the future looks like. Sarah Nove, an English major, originally thought she wanted to be a journalist while she was working at her high school paper, but when the pandemic hit and the news became more stressful, she had to start turning it off for her mental health. I will say that COVID definitely impacted my ideas, and what I want to be when I grow up and what Im interested in, she explained. And while she still loves editing, shes not sure that being a full-time journalist is the job for her.

When school went virtual in March, her high school newspaper training was turned upside down. I was in charge of training pretty much everybody with the help of some of the section editors. I felt bad on one hand for not being able to pass along the skills that people passed along to me. It was hard for me to feel like I was letting them down but also knowing I couldnt do anything about it, Nove said.

Though beach week wasnt on the docket for Nove, she had plans with her mom to visit Paris and Austria, something that they had been wanting to do for a long time. And thankfully, were pretty confident that well be able to make it work at some point but going on this trip before you become a college student, and have all the responsibilities of college on your plate, it did suck to miss out on that, she said.

Shes spent the summer taking classes and working as a babysitter, a job she loves. However, when it came to making the decision about living on campus, it was devastating to not feel comfortable enough to live in the dorm. I live in a condo with a single mom and a dog. I love it here and its the perfect amount of space for the two of us and our pup. But I was really looking forward to moving out and my mom was really looking forward to having alone time for once in her life, Nove said. Of course, its been hard on her just as much as its been hard on me, so theres the factor just wanting to be out on my own so badly and not being able to. And then on top of that, Im not a person with a huge circle of friends. I was really looking forward to branching out and meeting other people that shared similar interests and values.

While some are opting to stay at home, others, like Francesca Burton, a neuroscience and biochemistry double major, are living on campus this fall. After her plans to visit Canada with her mom and her plans to go to Florida with friends vanished, Burton spent her summer working at the local Boston Market. She hopes that spending the last few weeks of her high school career online has prepared her for online learning in college.

Im definitely disappointed were not going to have in-person classes because I have found I learn better in an in-person setting. But I think by now, Ive just gotten so used to the fact that we will probably have this weird online semester. Ive kind of processed everything, she said.

When it comes to fall activities, COVID-19 has left her mostly unsure. I saw that there was a cooking club that I was interested in. I was thinking of picking up Ultimate Frisbee just as a thing to try, which I think is going to be impacted, she said. So Im a little sad that I wont get wont get to try that out.

But overall, she still sees the fall in an optimistic light. Maryland has been doing a pretty good job on keeping cases down. We havent had a spike yet. I would say Im optimistic that things will go back to normal, said Burton. I think thats all we can do is be optimistic, and just try to make the most of this. I just hope that despite everything being online, we can still just be normal college kids instead of just kids going through a pandemic.

See the rest here:
'I'm definitely disappointed:' incoming freshmen face new set of challenges for the fall | The Retriever - The Retriever

University of East London lecturer says PHE report fails to address genetics – Newham Recorder

Video

PUBLISHED: 10:00 29 June 2020

Cash Boyle

Dr Winston Morgan, Reader in Toxicology and Clinical Biochemistry at the University of East London, says race and genetics are key omissions from the PHE report on coronavirus. Picture: University of East London

Archant

Email this article to a friend

To send a link to this page you must be logged in.

Dr Morgan a reader in toxicology and clinical biochemistry at the university commended the report for properly addressing the structural problems linked to racism which have caused Covid-19 to disproportionately impact BAME communities.

However, the lecturer criticised the complete lack of consideration given to the issue of genetics, and specifically to answering the question as to whether certain traits increase virus susceptibility.

Failing to adequately address this subject leaves the door open for continued speculation around race and genetics, said Dr Morgan.

This report was an opportunity to knock the speculation on its head, and allow for focus to be appropriately shifted to dealing with the damaging structural problems within society.

A spokesperson for PHE said: The review was not able to look at genetic factors and more research in this area is needed.

To complement the review, a research call by the National Institute for Health Research (NIHR) and UK Research and Innovation (UKRI) has jointly called for research proposals to investigate emerging evidence of an association between ethnicity and COVID-19 incidence and adverse health outcomes.

Dr Morgan also queried how the report framed its discussion of the relationship between the BAME community and the NHS: The report missed a number of opportunities, such as not to consider that historical racism will impact on both the speed and level of treatment BAME groups are likely to receive when they interact with the NHS.

Instead, it focused on the fact that as a result of historical racism BAME groups are less likely to seek care when needed.

Both arguments are underpinned by historical racism, and should have been given equal weight in the report: By omitting the former it has the feel of blaming the victims for not complaining.

PHE conceded that the report did not consider every issue: There are many impacts of systemic racism and PHEs qualitative report identified the issues that were raised repeatedly by stakeholders.

This does not mean that other factors are not relevant and confirms the need for further more detailed research studies on these issues.

Dr Morgan concluded that despite reservations over the lack of wider recommendation about tackling structural racism in wider society, all seven recommendations should be implemented.

If you value what this story gives you, please consider supporting the Newham Recorder. Click the link in the orange box below for details.

See the original post:
University of East London lecturer says PHE report fails to address genetics - Newham Recorder

Should we sequence newborns’ DNA? The answer is complicated, study finds – UC Berkeley

Newborn babies are regularly screened for serious medical conditions that could cause long-term damage if left untreated. A new study from UC Berkeley examines whether genetic sequencing should be included among these tests. (Public domain photo)

Many adults seek genetic counseling, or opt to send samples of their saliva to companies like 23andMe, to find out if the specific patterns in their DNA may put them at higher risk for developing disease. But many doctors and scientists including National Institutes of Health Director Francis Collins have predicted that, one day, genetic screening will be a routine health check performed on all newborn babies.

A new study led by researchers at the University of California, Berkeley; the University of California, San Francisco (UCSF); and Tata Consultancy Services is the first to comprehensively assess the potential of genomic sequencing to reveal health problems in newborns. The study, NBseq, compared how genomic sequencing fared against standard biochemical testing in identifying 48 rare metabolic disorders in newborns.

The results, published this week in the journal Nature Medicine, show that, when used alone, sequencing is not as accurate as standard biochemical tests, as it misses some sick babies while tagging many healthy ones as potentially ill.

However, the research team concluded that giving sequence data to doctors examining newborns whose illnesses were flagged by standard testing could aid in more precise and timely diagnoses. After careful vetting, sequencing might also enable screening for hundreds of treatable genetic diseases that currently cant be detected through biochemical testing.

Thirty years ago, when I was an undergraduate in the worlds first genome sequencing laboratory, my mentor gave talks predicting that, by 2030 or 2040, every newborn would leave the hospital with their genome on a CD-ROM, said study co-senior author Steven Brenner, a UC Berkeley professor and a member of UCSFs Institute for Human Genetics. This has become increasingly technically plausible, but the value of pervasive newborn sequencing and the risks have remained unclear. This work draws on a unique dataset to give unparalleled insight into the implications of sequencing all newborns to identify diseases without current symptoms.

It may seem surprising that genetic testing doesnt work as well as well as other methods for identifying genetic disease. But while the shortcomings of genetic sequencing could have many causes, the value of the technique will likely improve as scientists learn more about the specific genetic variants that lead to disease.

These are well-studied classic genetic conditions, but that does not mean we have found all the genes associated with them, said first author Aashish Adhikari, from UC Berkeleys Department of Plant and Microbial Biology and a member of UCSFs Institute for Human Genetics. Additional genes could be involved, as well as additional biological and environmental factors, that may limit our ability to predict disease from DNA sequences alone.

Soon after they are born, every baby in California receives a heel prick, releasing a small sample of blood that is saved on a piece of filter paper. These samples are collected to test for a series of rare metabolic conditions, known as inborn errors of metabolism, that show up as abnormal biochemical signatures. Many of these conditions dont exhibit clear symptoms right away, but can lead to serious health problems down the road, if left untreated.

Out of nearly 4.5 million newborns born in California between July 2005 to December 2013, more than 1,300 were found to have inborn errors of metabolism. To conduct the study, the team obtained a comprehensive set of de-identified samples from nearly all affected babies. They then optimized a technique to extract and accurately sequence the DNA from the filter paper samples, which had been saved and stored for years.

When we started, we did not know whether decade-old dried blood spots could generate good quality DNA sequences. If they were degraded, then most of the variants in the genome would actually just be errors, said Rajgopal Srinivasan, chief scientist of the life sciences research area at Tata Consultancy Services. We worked together to develop a battery of new analyses to confirm that the DNA sequences we found were trustworthy.

Standard biochemical screenings find 99% of babies with metabolic disorders, while giving a false positive rate of just 0.2%. However, the researchers found that genetic testing alone would have found only 88% of these cases, leaving about 160 babies with a false negative that could lead to serious consequences. It also would have incorrectly identified about 8,000 healthy babies each year as being at risk for disease, leading to unnecessary interventions.

However, the researchers also found cases where the original blood tests were inconclusive, but the results of the DNA sequencing would have allowed them to make a definitive diagnosis.

This kind of accuracy is key in screening tests, the researchers said, as most newborns with these conditions do not show symptoms right away.

All of the prior studies of utility of exome sequencing have started with a patient already in front of a doctor in other words, a patient with a problem, said Dr. Jennifer Puck, professor of pediatrics at UCSF and co-senior author of the study. You start with a clue in hand, a person with a particular difficulty, and youre trying to see if theres an underlying genetic reason for that. When you switch to screening mode, you dont have any clues. Most newborns look perfectly healthy.

See the original post:
Should we sequence newborns' DNA? The answer is complicated, study finds - UC Berkeley

Nanoscience Presents: Food Ingredient Formulation Development with Novel Real-time Technique – PR Web

QCM-D used for understanding the physical and biochemical characteristics of food ingredients at the molecular scale, mimicking real-time interactions for insights into food formulation.

PHOENIX (PRWEB) August 13, 2020

Nanoscience Instruments hosts researchers Dr. Alireza Abbaspourrad, the Yongkeun Joh Assistant Professor of Food Chemistry and Ingredient Technology, and his research associate, Dr. Younas Dadmohammadi as they present some of their novel findings during a free webinar on August 27th, 2020.

Understanding the physical and biochemical characteristics of food ingredients is a vital part of research in the fields of food chemistry and ingredient technology, especially as researchers make advancements toward natural and clean-label food ingredients. In Cornell Universitys Department of Food Science, part of the College of Agriculture and Life Sciences, the Abbaspourrad Lab is working on just that.

Food ingredients and their in-matrix interactions significantly determining the quality (i.e., color and texture) and perception profile (i.e., taste, flavor, and aroma) of food. Food shelf life is another critical factor influencing both quality and perception. Therefore, to move away from the old-fashioned method, cook and look, and embrace a more sustainable approach, the ingredient formulation is a key step. In this vein, understanding the physical and biochemical characteristics of food ingredients at the molecular scale and mimicking real-time molecule-molecule and molecule-saliva interactions yield insights into efficient food formulation and enhanced perception profile in the oral cavity. To achieve this goal and advance our understanding of food ingredients and turn that knowledge into practical applications, cutting-edge technology such as Quartz Crystal Microbalance with Dissipation is employed. Using this information, we can develop new formulations for food products with a better understanding of how the ingredients will play a role in food quality and desired perception.

In this webinar, we will discuss a couple of food applications using QCM-D information targeting (i) the encapsulation of bioactive component, N-Acetyl-L-Cysteine, to mask its off-flavor and (ii) improving the shelf life stability of Cphycocyanin (a natural blue colorant) in the beverage.

Register for the free webinar:https://bit.ly/2PVZjIF

For more information on the QCM-D technique visit nanoscience.com

About the presenters:

Alireza Abbaspourrad Bio:Dr. Abbaspourrad is an Assistant Professor of Food Chemistry and Ingredient Technology at Cornell University, Department of Food Science. He is co-author of 154 peer-reviewed publications and 13 provisional/granted patents. Due to his interest in microfluidic systems, he started to focus on microfluidic systems towards sperm sample preparation since September 2017, and so far, his group could file a patent on microfluidic-based sperm separation technology and submitted two papers in prestigious peer-reviewed journals. Dr. Abbaspourrad received his M.Sc. in Organic Chemistry from Ferdowsi University in Iran. He did his graduate work on synthesis and surface modification of zeolites at the Isfahan University of Technology, receiving his Ph.D. in Organic Chemistry in 2006 in Iran. He visited National Institute for Nanotechnology at the University of Alberta in Canada as a visiting scholar in 2003. Afterward, he established two chemical startups. In 2009, he joined Prof. David Weitzs group at the School of Engineering and Applied Sciences at Harvard University, where he studied fabrication of functional materials at interfaces, structural emulsions, encapsulation of ingredients, and controlled release systems using drop-based microfluidics as well as conventional microencapsulation techniques.

Younas Dadmohammadi Bio:Dr. Younas Dadmohammadi is a Research Associate at Cornell University. He is leading multi-disciplinary projects and mentoring a group of graduate and undergraduate students. His field of interest forges much-needed connections between engineering, food, and life science. Younas trained as a chemical engineer through a B.Sc., M.Sc., and Ph.D. from Iran. Younas has been experienced as an industry advisor for the chemical industry and served as faculty in universities for more than seven years. In 2009, Younas was invited to Texas A&M University as a Research Scholar working on cross-disciplinary projects. Then, he moved to Oklahoma State University, where he received his 2nd Ph.D. working on a DOE-funded project focusing on machine learning, modeling, and optimization integrating both microscopic and macroscopic scales. His findings were peer-reviewed and published in several papers. In 2014, Younas joined the industrial research consortium in Oklahoma, working directly with industry to raise funding and develop innovative solutions for industry challenges to minimize the research and development cost.

About Nanoscience InstrumentsNanoscience Instruments sells innovative and highest quality research and analytical instrumentation solutions. Servicing academia, industry and government partners by delivering specialty surface science instrumentations for nanoscale applications. Our portfolio consists of desktop scanning electron microscopes, nanofiber electrospinning instruments, nanoparticle generation instruments, sample preparation solutions, transmission electron microscopy solutions, micro-balance and contact angle tensiometery instrumentation. Visit nanoscience.com to learn more about the products as well as the consumables and accessories we provide.

Share article on social media or email:

Follow this link:
Nanoscience Presents: Food Ingredient Formulation Development with Novel Real-time Technique - PR Web

Student-faculty Research Team Assessing Early Markers and Dietary Treatment of Liver Cancer – Bethel University News

We cant really take vacations. The cells need to be taken care of. Its like having a dog, Korbyn Dahlquist 20 explained with only a hint of sarcasm last summer. At the time, the biochemistry and chemistry double major and Associate Professor of Chemistry Angela Stoeckman were embarking on a year-long Edgren Scholarship-funded research project focused on understanding the dietary influence on markers of metastatic hepatocellular carcinoma.

To achieve that, the team has been treating liver cancer cellsH4IIE, which can be bought online through distributorswith control substances or a saturated fatty acid called palmitate. The hope is to determine when cells are going through apoptosisdying because of the presence of extra lipidsand if theyre secreting an anti- or pro-inflammatory response in the form of cytokines. Thats like a chemical call for help that could flag the presence of further injury through a simple blood test.

To create the ideal setting for this type of work on fussy mammalian cell cultures, the team has created an intricate and incredibly hands-on process of sterilizing a biosafety cabinet with UV rays before growing cultures in optimal conditions over several days. Then they have to time their assays perfectly with the death of the cells to get the data they need.

They stain the apoptotic cells with fluorescent markers and run them through a flow cytometer. A million cells can be run through the machine at once, and it quantifies the amount of lipids present in specific populations, within a split second.

If people with the cancer have high levels of a certain cytokine, theres morbidity in the disease, Stoeckman explains. If person A is secreting, and B is not, perhaps A is more likely to die from their cancer. What Korbyn is noticing is that if these cancer cells are seeing palmitate, a saturated fatty acid, thats inducing them to secrete more cytokines, which is responsible for high morbidity. And maybe we can keep cytokines under control simply by recommending a certain diet!

NAFLD is a condition that impacts an estimated one in three Americans, and it can progress into hepatocellular carcinoma, the fastest-growing type of liver cancer globally. Its responsible for the third highest number of cancer deaths, so detecting NAFLD early could mean saving lives in the long term. Currently, it can only be identified by biopsy, which is both invasive and expensive.

View post:
Student-faculty Research Team Assessing Early Markers and Dietary Treatment of Liver Cancer - Bethel University News